Common, intermediate and well-documented HLA alleles in world populations: CIWD version 3.0.0.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
06 2020
Historique:
received: 23 08 2019
revised: 16 01 2020
accepted: 20 01 2020
pubmed: 24 1 2020
medline: 22 6 2021
entrez: 24 1 2020
Statut: ppublish

Résumé

A catalog of common, intermediate and well-documented (CIWD) HLA-A, -B, -C, -DRB1, -DRB3, -DRB4, -DRB5, -DQB1 and -DPB1 alleles has been compiled from over 8 million individuals using data from 20 unrelated hematopoietic stem cell volunteer donor registries. Individuals are divided into seven geographic/ancestral/ethnic groups and data are summarized for each group and for the total population. P (two-field) and G group assignments are divided into one of four frequency categories: common (≥1 in 10 000), intermediate (≥1 in 100 000), well-documented (≥5 occurrences) or not-CIWD. Overall 26% of alleles in IPD-IMGT/HLA version 3.31.0 at P group resolution fall into the three CIWD categories. The two-field catalog includes 18% (n = 545) common, 17% (n = 513) intermediate, and 65% (n = 1997) well-documented alleles. Full-field allele frequency data are provided but are limited in value by the variations in resolution used by the registries. A recommended CIWD list is based on the most frequent category in the total or any of the seven geographic/ancestral/ethnic groups. Data are also provided so users can compile a catalog specific to the population groups that they serve. Comparisons are made to three previous CWD reports representing more limited population groups. This catalog, CIWD version 3.0.0, is a step closer to the collection of global HLA frequencies and to a clearer view of HLA diversity in the human population as a whole.

Identifiants

pubmed: 31970929
doi: 10.1111/tan.13811
pmc: PMC7317522
doi:

Substances chimiques

Histocompatibility Antigens Class I 0
Histocompatibility Antigens Class II 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

516-531

Informations de copyright

© 2020 The Authors. HLA published by John Wiley & Sons Ltd.

Références

Tissue Antigens. 2013 Apr;81(4):194-203
pubmed: 23510415
HLA. 2018 Oct;92(4):206-214
pubmed: 30117303
Nat Rev Immunol. 2011 Nov 11;11(12):823-36
pubmed: 22076556
HLA. 2017 Feb;89(2):104-113
pubmed: 28102034
Bone Marrow Transplant. 2010 May;45(5):811-8
pubmed: 20154736
Trends Genet. 2012 Oct;28(10):480-6
pubmed: 22867968
Annu Rev Immunol. 2016 May 20;34:265-97
pubmed: 26907214
Hum Immunol. 2007 May;68(5):392-417
pubmed: 17462507
Biol Blood Marrow Transplant. 2019 Aug;25(8):e268-e269
pubmed: 31145991
PLoS One. 2015 Aug 19;10(8):e0135960
pubmed: 26287376
Cell. 2017 Feb 9;168(4):600-612
pubmed: 28187283
Hum Immunol. 2011 Dec;72(12):1214-6
pubmed: 21723898
Blood. 2007 Dec 15;110(13):4576-83
pubmed: 17785583
Annu Rev Immunol. 2015;33:169-200
pubmed: 25493333
Transplant Direct. 2017 Apr 07;3(5):e152
pubmed: 28573187
HLA. 2018 Oct;92(4):199-205
pubmed: 30073798
Immunol Rev. 2015 Sep;267(1):148-66
pubmed: 26284476
Nucleic Acids Res. 2015 Jan;43(Database issue):D423-31
pubmed: 25414341
HLA. 2018 Mar;91(3):175-186
pubmed: 29327506
HLA. 2019 Jun;93(6):474-483
pubmed: 30907066
Transplantation. 2016 May;100(5):1094-102
pubmed: 26901078
Hum Immunol. 2019 Jan;80(1):79-84
pubmed: 29684413
Biol Blood Marrow Transplant. 2008 Sep;14(9 Suppl):37-44
pubmed: 18721779
Tissue Antigens. 2010 Apr;75(4):291-455
pubmed: 20356336
Hum Immunol. 2016 Jul;77(7):542-9
pubmed: 27163154
Blood. 2014 Oct 16;124(16):2596-606
pubmed: 25161269
Genome Biol. 2017 Apr 27;18(1):76
pubmed: 28449694
Immunogenetics. 2017 Aug;69(8-9):617-630
pubmed: 28695285
Bone Marrow Transplant. 2013 Nov;48(11):1387-8
pubmed: 23811817
Transplantation. 2017 May;101(5):e170-e177
pubmed: 28221244
Tissue Antigens. 2011 Nov;78(5):333-44
pubmed: 21988720
Biol Blood Marrow Transplant. 2019 Mar;25(3):443-450
pubmed: 30935664
PLoS Genet. 2017 Jun 26;13(6):e1006862
pubmed: 28650991
Immunogenetics. 2018 Jan;70(1):5-27
pubmed: 28687858
HLA. 2020 Jun;95(6):516-531
pubmed: 31970929
Hum Mol Genet. 2018 Aug 1;27(R2):R209-R218
pubmed: 29741686

Auteurs

Carolyn K Hurley (CK)

Department of Oncology, Georgetown University, Washington, District of Columbia.

Jane Kempenich (J)

National Marrow Donor Program, Minneapolis, Minnesota.

Kim Wadsworth (K)

National Marrow Donor Program, Minneapolis, Minnesota.

Jürgen Sauter (J)

DKMS, Tübingen, Germany.

Jan A Hofmann (JA)

DKMS, Tübingen, Germany.

Daniel Schefzyk (D)

DKMS, Tübingen, Germany.

Alexander H Schmidt (AH)

DKMS, Tübingen, Germany.

Pablo Galarza (P)

Argentine HSC Donors Registry, Buenos Aires, Argentina.

Maria B R Cardozo (MBR)

Argentine HSC Donors Registry, Buenos Aires, Argentina.

Malgorzata Dudkiewicz (M)

Central Unrelated Potential Bone Marrow Donor and Cord Blood Registry POLTRANSPLANT, Warsaw, Poland.

Lucie Houdova (L)

University of West Bohemia, New Technologies for the Information Society, Pilsen, Czech Republic.

Pavel Jindra (P)

Czech National Marrow Donors Registry and University Hospital Pilsen, Pilsen, Czech Republic.

Betina S Sorensen (BS)

Danish Stem Cell Donors-West, Aarhus University Hospital, Aarhus, Denmark.

Latha Jagannathan (L)

DKMS BMST Foundation India, Bangalore, India.
Bangalore Medical Services Trust, Bangalore, India.

Ankit Mathur (A)

Bangalore Medical Services Trust, Bangalore, India.

Tiina Linjama (T)

Finnish Stem Cell Registry, Helsinki, Finland.

Tigran Torosian (T)

Fundacja DKMS, Warsaw, Poland.

Rafi Freudenberger (R)

Gift of Life Marrow Registry, Florida.

Anastasios Manolis (A)

Hellenic Transplant Organization (HTO), Athens, Greece.

John Mavrommatis (J)

Hellenic Transplant Organization (HTO), Athens, Greece.

Nezih Cereb (N)

DATRI Blood Stem Cell Donor Registry, Chennai, India.

Sigal Manor (S)

Israel-Ezer Mizion Bone Marrow Donor Registry, Bnei Brak, Israel.

Nira Shriki (N)

Israel-Ezer Mizion Bone Marrow Donor Registry, Bnei Brak, Israel.

Nicoletta Sacchi (N)

Italian Bone Marrow Donor Registry, Genoa, Italy.

Reem Ameen (R)

Kuwait National Stem Cell Registry, Jabriya, Kuwait.

Raewyn Fisher (R)

New Zealand Bone Marrow Donor Registry, Auckland, New Zealand.

Heather Dunckley (H)

New Zealand Blood Service, Auckland, New Zealand.

Irene Andersen (I)

Norwegian Bone Marrow Donor Registry, Oslo, Norway.

Ahmed Alaskar (A)

Saudi Stem Cell Donor Registry, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.

Mohsen Alzahrani (M)

Saudi Stem Cell Donor Registry, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.

Ali Hajeer (A)

Saudi Stem Cell Donor Registry, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.

Dunia Jawdat (D)

Saudi Stem Cell Donor Registry, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.

Grazia Nicoloso (G)

Swiss Blood Stem Cells, Bern, Switzerland.

Pawinee Kupatawintu (P)

Thai National Stem Cell Donor Registry, Bangkok, Thailand.

Louise Cho (L)

The Bone Marrow Donor Programme, Singapore.

Ashminder Kaur (A)

The Bone Marrow Donor Programme, Singapore.

Mats Bengtsson (M)

Tobias Registry of Swedish Bone Marrow Donors and Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Jason Dehn (J)

National Marrow Donor Program, Minneapolis, Minnesota.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH